Cargando…
Whole-genome sequencing of rifampicin-resistant M. tuberculosis strains identifies compensatory mutations in RNA polymerase
Drug-resistant bacteria are emerging worldwide, despite frequently being less fit than drug-susceptible strains(1). Data from model systems suggest the fitness cost of antimicrobial resistance can be mitigated by compensatory mutations(2). However, current evidence that compensatory evolution plays...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246538/ https://www.ncbi.nlm.nih.gov/pubmed/22179134 http://dx.doi.org/10.1038/ng.1038 |
_version_ | 1782219962571554816 |
---|---|
author | Comas, Iñaki Borrell, Sonia Roetzer, Andreas Rose, Graham Malla, Bijaya Kato-Maeda, Midori Galagan, James Niemann, Stefan Gagneux, Sebastien |
author_facet | Comas, Iñaki Borrell, Sonia Roetzer, Andreas Rose, Graham Malla, Bijaya Kato-Maeda, Midori Galagan, James Niemann, Stefan Gagneux, Sebastien |
author_sort | Comas, Iñaki |
collection | PubMed |
description | Drug-resistant bacteria are emerging worldwide, despite frequently being less fit than drug-susceptible strains(1). Data from model systems suggest the fitness cost of antimicrobial resistance can be mitigated by compensatory mutations(2). However, current evidence that compensatory evolution plays any significant role in the success of drug-resistant bacteria in human populations is weak(3–6). Here we describe a set of novel compensatory mutations in the RNA polymerase of rifampicin-resistant Mycobacterium tuberculosis, the etiologic agent of human tuberculosis (TB). M. tuberculosis strains harbouring these compensatory mutations exhibited a high competitive fitness in vitro. Moreover, these mutations were associated with high in vivo fitness as determined by their relative clinical frequency across patient populations. Importantly, in countries with the world’s highest incidence of multidrug-resistant (MDR) TB(7), more than 30% of MDR clinical isolates had such a mutation. Our findings support a role for compensatory evolution in the global epidemics of MDR-TB(8). |
format | Online Article Text |
id | pubmed-3246538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
record_format | MEDLINE/PubMed |
spelling | pubmed-32465382012-07-01 Whole-genome sequencing of rifampicin-resistant M. tuberculosis strains identifies compensatory mutations in RNA polymerase Comas, Iñaki Borrell, Sonia Roetzer, Andreas Rose, Graham Malla, Bijaya Kato-Maeda, Midori Galagan, James Niemann, Stefan Gagneux, Sebastien Nat Genet Article Drug-resistant bacteria are emerging worldwide, despite frequently being less fit than drug-susceptible strains(1). Data from model systems suggest the fitness cost of antimicrobial resistance can be mitigated by compensatory mutations(2). However, current evidence that compensatory evolution plays any significant role in the success of drug-resistant bacteria in human populations is weak(3–6). Here we describe a set of novel compensatory mutations in the RNA polymerase of rifampicin-resistant Mycobacterium tuberculosis, the etiologic agent of human tuberculosis (TB). M. tuberculosis strains harbouring these compensatory mutations exhibited a high competitive fitness in vitro. Moreover, these mutations were associated with high in vivo fitness as determined by their relative clinical frequency across patient populations. Importantly, in countries with the world’s highest incidence of multidrug-resistant (MDR) TB(7), more than 30% of MDR clinical isolates had such a mutation. Our findings support a role for compensatory evolution in the global epidemics of MDR-TB(8). 2011-12-18 /pmc/articles/PMC3246538/ /pubmed/22179134 http://dx.doi.org/10.1038/ng.1038 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Comas, Iñaki Borrell, Sonia Roetzer, Andreas Rose, Graham Malla, Bijaya Kato-Maeda, Midori Galagan, James Niemann, Stefan Gagneux, Sebastien Whole-genome sequencing of rifampicin-resistant M. tuberculosis strains identifies compensatory mutations in RNA polymerase |
title | Whole-genome sequencing of rifampicin-resistant M. tuberculosis strains identifies compensatory mutations in RNA polymerase |
title_full | Whole-genome sequencing of rifampicin-resistant M. tuberculosis strains identifies compensatory mutations in RNA polymerase |
title_fullStr | Whole-genome sequencing of rifampicin-resistant M. tuberculosis strains identifies compensatory mutations in RNA polymerase |
title_full_unstemmed | Whole-genome sequencing of rifampicin-resistant M. tuberculosis strains identifies compensatory mutations in RNA polymerase |
title_short | Whole-genome sequencing of rifampicin-resistant M. tuberculosis strains identifies compensatory mutations in RNA polymerase |
title_sort | whole-genome sequencing of rifampicin-resistant m. tuberculosis strains identifies compensatory mutations in rna polymerase |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246538/ https://www.ncbi.nlm.nih.gov/pubmed/22179134 http://dx.doi.org/10.1038/ng.1038 |
work_keys_str_mv | AT comasinaki wholegenomesequencingofrifampicinresistantmtuberculosisstrainsidentifiescompensatorymutationsinrnapolymerase AT borrellsonia wholegenomesequencingofrifampicinresistantmtuberculosisstrainsidentifiescompensatorymutationsinrnapolymerase AT roetzerandreas wholegenomesequencingofrifampicinresistantmtuberculosisstrainsidentifiescompensatorymutationsinrnapolymerase AT rosegraham wholegenomesequencingofrifampicinresistantmtuberculosisstrainsidentifiescompensatorymutationsinrnapolymerase AT mallabijaya wholegenomesequencingofrifampicinresistantmtuberculosisstrainsidentifiescompensatorymutationsinrnapolymerase AT katomaedamidori wholegenomesequencingofrifampicinresistantmtuberculosisstrainsidentifiescompensatorymutationsinrnapolymerase AT galaganjames wholegenomesequencingofrifampicinresistantmtuberculosisstrainsidentifiescompensatorymutationsinrnapolymerase AT niemannstefan wholegenomesequencingofrifampicinresistantmtuberculosisstrainsidentifiescompensatorymutationsinrnapolymerase AT gagneuxsebastien wholegenomesequencingofrifampicinresistantmtuberculosisstrainsidentifiescompensatorymutationsinrnapolymerase |